Study on the rule of medication in the treatment of hypertension with anxious neurosis based on the implicit structure model
LIN Ping1 CUI Weifeng2 QING Hui2 LI Ling3 LEI Siyuan1
1.The First Clinical Medical College, Henan University of Chinese Medicine, Henan Province, Zhengzhou 450046, China;
2.Henan Academy of Traditional Chinese Medicine, Henan Province, Zhengzhou 450004, China;
3.Department of Hypertension, Henan Provincial People’s Hospital, Henan Province, Zhengzhou 450003, China
Abstract：Objective To explore the rule of medication based on syndrome differentiation in treating hypertension with anxious neurosis based on the implicit structure model, and to provide evidence for clinical syndrome differentiation and medication. Methods A total of 180 patients with hypertension with anxious neurosis who were outpatients or inpatients in the Department of Hypertension, the Affiliated Hospital of Henan Academy of Traditional Chinese Medicine and Henan Provincial People’s Hospital from January 2018 to August 2020 were collected through a unified clinical information collection table. The implicit structure model of Lantern 5.0 was constructed with symptoms and Chinese medicine as the factors, and implicit interpretation was carried out, and SAS 10.0 was used to mine the association rules of drug-drug and drug-symptom. Results Six common witness types of hypertension with anxious neurosis were summarized, which were syndrome of hyperactivity of yang due to yin deficiency, syndrome of stagnation of liver qi and spleen deficiency, syndrome of phlegm-turbidity accumulated in interior, syndrome of deficiency of both heart and spleen, syndrome of kidney yin insufficiency, syndrome of qi stagnation and blood stasis. Commonly used drugs were Poria, Gastrodiae Rhizoma, Citri Reticulatae Pericarpium, Glycyrrhizae Radix Et Rhizoma Praeparata Cum Melle, Pinelliae Rhizoma, Angelicae Sinensis Radix, Atractylodis Macrocephalae Rhizoma, Bupleuri Radix, Chuanxiong Rhizoma, Scutellariae Radix, Ziziphi Spinosae Semen Tostum, Paeoniae Radix Alba, Uncariae Ramulus Cum Uncis, Gardeniae Fructus, Codonopsis Radix, etc. Commonly used formulations were Tianma Gouteng Drink, Suanzaoren Decoction, Erchen Decoction, Chaiqin Decoction, Qiju Dihuang Decoction,Chaihu Shugan Powder, etc. Conclusion The patients with hypertension with anxious neurosis are mostly phlegm and turbidities. The treatment is based on syndrome differentiation, such as dispersing liver and regulating qi, nourishing liver and kidney, promoting blood circulation for removing blood stasis, nourishing heart for tranquillization and so on. The roots are treated following the principles of invigorating the spleen and eliminating phlegm, and symptoms following the principles of regulating qi, invigorating blood, nourishing yin, and soothing the nerves.
林萍1 崔伟锋2 庆慧2 李玲3 雷斯媛1. 基于隐结构模型辨证论治高血压伴焦虑症用药规律研究[J]. 中国医药导报, 2022, 19(35): 125-129,139.
LIN Ping1 CUI Weifeng2 QING Hui2 LI Ling3 LEI Siyuan1. Study on the rule of medication in the treatment of hypertension with anxious neurosis based on the implicit structure model. 中国医药导报, 2022, 19(35): 125-129,139.
[1] 张勃，瞿婷婷，申曙光.基层医疗卫生机构的基本医疗服务范围研究——基于常见病、多发病的视角[J].中国医院管理，2016，36（8）：23-25.
[2] 黄裕立.高血压前期和心脑肾血管风险相关性的研究[D].广州：南方医科大学，2014.
[3] 朱晓旭，谢鸣.焦虑症中医药治疗研究现状（综述）[J].北京中医药大学学报，2002，25（3）：62-65.
[4] Liu MY，Li N，Li WA，et al. Association between psychosocial stress and hypertension：a systematic review and meta- analysis [J]. Neurol Res，2017，39（6）：573-580.
[5] 王谨敏，周小炫，吴成翰，等.中医治未病·高血压伴发焦虑专家共识[J].中华中医药学刊，2020，38（3）：29-32.
[6] Liao J，Wang X，Liu C，et al. Prevalence and related risk factors of hypertensive patients with co-morbid anxiety and/or depression in community：a cross-sectional study [J]. Zhonghua Yi Xue Za Zhi，2014 ，94（1）：62-66.
[7] Bussotti M，Sommaruga M. Anxiety and depression in patients with pulmonary hypertension：impact and management challenges [J]. Vasc Health Risk Manag，2018，14：349-360.
[8] Johnson HM. Anxiety and Hypertension：Is There a Link? A Literature Review of the Comorbidity Relationship Between Anxiety and Hypertension[J]. Curr Hypertens Rep，2019，21（9）：66.
[9] 雷斯媛，庆慧.高血压与焦虑症共病的研究进展[J].中医研究，2018，31（9）：67-71.
[10] 任胜洪，石燕芳，李青，等.解郁平肝汤治疗高血压合并焦虑症肝郁化火型的临床观察[J].世界中医药，2017， 12（6）：1294-1297.
[11] 张艳.加味酸枣仁汤联合西药治疗高血压伴焦虑的疗效分析[J].江西中医药，2020，51（9）：42-43.
[12] 彭晓明，唐珂.龙牡安神胶囊对原发性高血压患者焦虑障碍的疗效观察[J].甘肃医药，2021，40（7）：595-596， 610.
[13] 李继明.论“证”的主观性与客观性[J].成都中医药大学学报，2006，29（3）：1-2，5.
[14] 中国高血压防治指南（2018年修订版）[J].中国心血管杂志，2019，24（1）：24-56.
[15] World Health Organization. ICD-10 classification of Mental and behavioral disorders. Disorders criteria for research [M]. Geneva：World Health Organization，1993.
[16] 郑筱萸.中药新药临床研究指导原则[M].北京：中国医药科技出版社，2002：77.
[17] 中华中医药学会.中医内科常见病诊疗指南·中医病证部分[M].北京：中国中医药出版社，2008.
[18] 周仲瑛.中医内科学[M].北京：中国中医药出版社，2007：2.
[19] 国家技术监督局.中医临床诊疗术语：GB/T16751.2—1997[Z].北京：中国标准出版社，1997．
[20] 陈家旭.中医诊断学[M].北京：人民卫生出版社，2016．
[21] 国家药典委员会.中华人民共和国药典[S]一部.北京：中国医药科技出版社，2015.
[22] 孙伟茗，焦晓民.高血压中医病名、病因、病机研究进展[J].实用中医内科杂志，2021，35（1）：101-105.
[23] 崔欣.基于仲景情志病证治理论的焦虑症病因病机研究[D].济南：山东中医药大学，2014.
[24] 张颖，许红峰，杨帆.高血压伴焦虑血压变异性与中医证型之间的相关性研究[J].中西医结合心血管病电子杂志，2019，7（11）：160.
[25] 刘倩.高血压伴焦虑状态患者与中医证型关系的研究[D].乌鲁木齐：新疆医科大学，2019.
[26] 张智芳.高血压与抑郁症、焦虑症的相关性及中医证型的探讨[D].北京：北京中医药大学，2013.
[27] 钟森杰，李静，李琳，等.“以方测证”在中医证候模型研究中的应用述评[J].中华中医药学刊，2021，39（2）：48- 50.
[28] 张昕洋，傅延龄，傅晨.中医“以方测证”认识方法初探[J].北京中医药，2018，37（9）：825-827.
[29] 徐伟超，许玉龙，张增博，等.基于隐结构模型的名老中医药专家辨证论治京津冀地区慢性萎缩性胃炎用药规律研究[J].中国中药杂志，2020，45（7）：1691-1697.
[30] 王烨燃，张洋，秦琦冰，等.基于数据挖掘的胃火炽盛型消渴病方剂的用药规律分析[J].中国中药杂志，2020， 45（1）：196-201.
[31] 闫梦晗，李晓，姜月华.半夏白术天麻汤的临床应用及药理研究进展[J].中西医结合心脑血管病杂志，2020， 18（14）：2265-2268.
[32] 陈丽平，李建生，蔡永敏.基于数据挖掘的名老中医应用二陈汤规律分析[J].中国实验方剂学杂志，2017，23（12）：201-207.
[33] 王伟斌.基于古今医案的郁证辨治规律研究[D].北京：中国中医科学院，2019.
[34] 代洪绪，翟文姬，项聿华.半夏白术天麻汤化裁治疗痰湿壅盛证原发性高血压的临床效果[J].中国当代医药，2022，29（1）：141-144.
[35] 徐男，王亮，时海燕，等.基于整合药理学平台探究半夏白术天麻汤治疗高血压的分子机制[J].中国实验方剂学杂志，2019，25（2）：109-117.
京公网安备 11010502046598号